{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:19:35Z","timestamp":1782818375913,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40123-016-0062-6","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T11:59:10Z","timestamp":1473681550000},"page":"147-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ocriplasmin for Treatment of Vitreomacular Traction: An Update"],"prefix":"10.1007","volume":"5","author":[{"given":"Mohammed Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"issue":"2","key":"62_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02160337","volume":"225","author":"J Sebag","year":"1987","unstructured":"Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol. 1987;225(2):89\u201393.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"62_CR2","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611\u20139.","journal-title":"Ophthalmology"},{"key":"62_CR3","volume-title":"Stereoscopic atlas of macular diseases: diagnosis and treatment","author":"J Gass","year":"1997","unstructured":"Gass J. Stereoscopic atlas of macular diseases: diagnosis and treatment. 4th ed. St. Louis: Mosby; 1997.","edition":"4"},{"issue":"10","key":"62_CR4","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/IAE.0b013e3182a6b3e2","volume":"33","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson ARH, et al. Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina. 2013;33(10):2012\u20137.","journal-title":"Retina"},{"issue":"9","key":"62_CR5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ophtha.2014.03.029","volume":"121","author":"JS Chang","year":"2014","unstructured":"Chang JS, Smiddy WE. Cost evaluation of surgical and pharmaceutical options in treatment for vitreomacular adhesions and macular holes. Ophthalmology. 2014;121(9):1720\u20136.","journal-title":"Ophthalmology"},{"issue":"7","key":"62_CR6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","volume":"367","author":"P Stalmans","year":"2012","unstructured":"Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367(7):606\u201315.","journal-title":"N Engl J Med"},{"issue":"9","key":"62_CR7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamaophthalmol.2015.1746","volume":"133","author":"R Varma","year":"2015","unstructured":"Varma R, Haller JA, Kaiser PK. Improvement in patient-reported visual function after ocriplasmin for vitreomacular adhesion: results of the Microplasmin for Intravitreous Injection-Traction Release Without Surgical Treatment (MIVI-TRUST) Trials. JAMA Ophthalmol. 2015;133(9):997\u20131004.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"62_CR8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/IAE.0000000000000508","volume":"35","author":"A Gandorfer","year":"2015","unstructured":"Gandorfer A, Benz MS, Haller JA, Stalmans P, Pakola SJ, Girach A, et al. Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion\/vitreomacular traction, including when associated with macular hole. Retina. 2015;35(6):1151\u20137.","journal-title":"Retina"},{"issue":"1","key":"62_CR9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","volume":"122","author":"JA Haller","year":"2015","unstructured":"Haller JA, Stalmans P, Benz MS, et al. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology. 2015;122(1):117\u201322.","journal-title":"Ophthalmology"},{"key":"62_CR10","unstructured":"Kaiser PK. The OASIS study: evaluating ocriplasmin for the treatment of symptomatic VMA\/VMT including macular hole over 2 years. In: American Academy of Ophthalmology annual meeting retina subspecialty day, Las Vegas, NV; 2015."},{"issue":"3","key":"62_CR11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","volume":"98","author":"RP Singh","year":"2014","unstructured":"Singh RP, Li A, Bedi R, Srivastava S, Sears JE, Ehlers JP, et al. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol. 2014;98(3):356\u201360.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"62_CR12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/23258160-20130715-05","volume":"44","author":"BT Kim","year":"2013","unstructured":"Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM, et al. Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina. 2013;44(4):334\u201343.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"62_CR13","doi-asserted-by":"crossref","first-page":"20.e1","DOI":"10.1016\/j.ajo.2014.09.015","volume":"159","author":"DJ Warrow","year":"2015","unstructured":"Warrow DJ, Lai MM, Patel A, Raevis J, Berinstein DM. Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin. Am J Ophthalmol. 2015;159(1):20.e1\u201330.e1.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"62_CR14","doi-asserted-by":"crossref","first-page":"861.e2","DOI":"10.1016\/j.ajo.2015.01.034","volume":"159","author":"P Sharma","year":"2015","unstructured":"Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho A, et al. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol. 2015;159(5):861.e2\u2013867.e2.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"62_CR15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00417-016-3363-5","volume":"254","author":"I Chatziralli","year":"2016","unstructured":"Chatziralli I, Theodossiadis G, Xanthopoulou P, Miligkos M, Sivaprasad S, Theodossiadis P. Ocriplasmin use for vitreomacular traction and macular hole: a meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications. Graefes Arch Clin Exp Ophthalmol. 2016;254(7):1247\u201356.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"62_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3928\/23258160-20140709-05","volume":"45","author":"JB Miller","year":"2014","unstructured":"Miller JB, Kim LA, Wu DM, Vavvas DG, Eliott D, Husain D. Ocriplasmin for treatment of stage 2 macular holes: early clinical results. Ophthalmic Surg Lasers Imaging Retina. 2014;45(4):293\u20137.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"62_CR17","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.ajo.2015.03.017","volume":"160","author":"PU Dugel","year":"2015","unstructured":"Dugel PU, Regillo C, Eliott D. characterization of anatomic and visual function outcomes in patients with full-thickness macular hole in ocriplasmin phase 3 trials. Am J Ophthalmol. 2015;160(1):94.e1\u201399.e1.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"62_CR18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/eye.2016.42","volume":"30","author":"DHW Steel","year":"2016","unstructured":"Steel DHW, Parkes C, Papastavrou VT, Avery PJ, El-Ghrably IA, Habib MS, et al. Predicting macular hole closure with ocriplasmin based on spectral domain optical coherence tomography. Eye. 2016;30(5):740\u20135.","journal-title":"Eye"},{"key":"62_CR19","first-page":"1","volume":"17","author":"MA Khan","year":"2015","unstructured":"Khan MA, Shahlaee A, Ho AC. Reopening of a full-thickness macular hole 2 years after pharmacologic closure with ocriplasmin. JAMA Ophthalmol. 2015;17:1\u20132.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"62_CR20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/eye.2013.94","volume":"27","author":"KB Freund","year":"2013","unstructured":"Freund KB, Shah SA, Shah VP. Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin. Eye. 2013;27(6):773\u20134.","journal-title":"Eye"},{"issue":"4","key":"62_CR21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamaophthalmol.2013.8142","volume":"132","author":"AT Fahim","year":"2014","unstructured":"Fahim AT, Khan NW, Johnson MW. Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection. JAMA Ophthalmol. 2014;132(4):484\u20136.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"62_CR22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamaophthalmol.2013.8258","volume":"132","author":"MD Tibbetts","year":"2014","unstructured":"Tibbetts MD, Reichel E, Witkin AJ. Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography. JAMA Ophthalmol. 2014;132(4):487\u201390.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"62_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ICB.0000000000000120","volume":"9","author":"C Quezada Ruiz","year":"2015","unstructured":"Quezada Ruiz C, Pieramici DJ, Nasir M, Rabena M, Avery RL. Severe acute vision loss, dyschromatopsia, and changes in the ellipsoid zone on SD-OCT associated with intravitreal ocriplasmin injection. Retin Cases Brief Rep. 2015;9(2):145\u20138.","journal-title":"Retin Cases Brief Rep"},{"issue":"2","key":"62_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaophthalmol.2014.4484","volume":"133","author":"DC Beebe","year":"2015","unstructured":"Beebe DC. Understanding the adverse effects of ocriplasmin. JAMA Ophthalmol. 2015;133(2):229.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"62_CR25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/IAE.0000000000000519","volume":"35","author":"P Hahn","year":"2015","unstructured":"Hahn P, Chung MM, Flynn HW, Huang SS, Kim JE, Mahmoud TH, et al. Safety profile of ocriplasmin for symptomatic vitreomacular adhesion: a comprehensive analysis of premarketing and postmarketing experiences. Retina. 2015;35(6):1128\u201334.","journal-title":"Retina"},{"issue":"2","key":"62_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3928\/23258160-20160126-09","volume":"47","author":"SP Shah","year":"2016","unstructured":"Shah SP, Jeng-Miller KW, Fine HF, Wheatley HM, Roth DB, Prenner JL. Post-marketing survey of adverse events following ocriplasmin. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):156\u201360.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"62_CR27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/IAE.0000000000000755","volume":"36","author":"E Nudleman","year":"2016","unstructured":"Nudleman E, Franklin MS, Wolfe JD, Williams GA, Ruby AJ. Resolution of subretinal fluid and outer retinal changes in patients treated with ocriplasmin. Retina. 2016;36(4):738\u201343.","journal-title":"Retina"},{"issue":"6","key":"62_CR28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/IAE.0000000000000544","volume":"35","author":"C Quezada-Ruiz","year":"2015","unstructured":"Quezada-Ruiz C, Pieramici DJ, Nasir M, Rabena M, Steinle N, Castellarin AA, et al. Outer retina reflectivity changes on SD-OCT after intravitreal ocriplasmin for vitreomacular traction and macular hole. Retina. 2015;35(6):1144\u201350.","journal-title":"Retina"},{"issue":"12","key":"62_CR29","doi-asserted-by":"crossref","first-page":"2506.e2","DOI":"10.1016\/j.ophtha.2014.07.044","volume":"121","author":"Y Itoh","year":"2014","unstructured":"Itoh Y, Kaiser PK, Singh RP, Srivastava SK, Ehlers JP. Assessment of retinal alterations after intravitreal ocriplasmin with spectral-domain optical coherence tomography. Ophthalmology. 2014;121(12):2506.e2\u20132507.e2.","journal-title":"Ophthalmology"},{"key":"62_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001110","author":"Y Itoh","year":"2016","unstructured":"Itoh Y, Ehlers JP. Ellipsoid zone mapping and outer retinal characterization after intravitreal ocriplasmin. Retina. 2016. doi: 10.1097\/IAE.0000000000001110","journal-title":"Retina"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-016-0062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:33:51Z","timestamp":1498343631000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40123-016-0062-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s40123-016-0062-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}